-
July 12: The Week in Cancer News
Standard screening may not catch endometrial cancer in Black women, and a cancer patient receives a voice box transplant for the first time.
by Thomas Celona
-
More Patients Participating in Cancer Research
A higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
-
July 5: The Week in Cancer News
Neuropathy may be prevented with an exercise program, and prostate cancer screening standards may not be appropriate for transgender women taking estrogen.
by Eric Fitzsimmons
-
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung Cancer
The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore
-
June 28: The Week in Cancer News
Acupuncture helps manage side effects of endocrine therapy, and adding chemotherapy before surgery delays progression in pancreatic cancer.
by Marci A. Landsmann
-
Self-collection Broadens Access to HPV Screening
FDA approval allows patients to collect samples for HPV test, lowering a barrier to an important cancer prevention tool.
by Taneia Surles
-
June 21: The Week in Cancer News
Risk for cancer and cardiovascular disease linked to air pollution, and three cancer drugs could face generic competition by 2028.
by Kevin McLaughlin
-
June 14: The Week in Cancer News
Lung cancer screening linked to lower mortality in real-world data, and researchers study unusual cancer patterns after COVID-19 infection.
by Eric Fitzsimmons
-
To Understand Disparities, Look at the Broader Contexts
Researchers at the AACR Annual Meeting 2024 consider ways in which social and economic factors like location affect cancer risk and outcomes.
by Eric Fitzsimmons
-
June 7: The Week in Cancer News
Research supports reducing the intensity of cancer treatment, and barriers can prevent members of the LGBTQ+ community from receiving cancer screening and care.
by Thomas Celona
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff